Effects of Probiotics on Symptoms of Constipation in Adults With Functional Constipation
NCT ID: NCT06969872
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
165 participants
INTERVENTIONAL
2024-12-27
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics Alleviate Functional Constipation in Adults
NCT06879587
Probiotics for Alleviating Functional Constipation in Adults
NCT06637397
Multi-strain Probiotic Effects on Self-Reported Constipation
NCT07275866
Efficacy of Probiotic Against Functional Constipation
NCT06122558
Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.
NCT02189707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
The composition of placebo capsules is same as the experimental capsules, except that they don't contain probiotics.
Placebo
Take a capsule of placebo within 30 minutes after breakfast, and once a day.
Low dose of ABKefir
Low dose of probiotics, 5×10\^9 CFU/capsule
Probiotics (ABKefir)
Take a capsule of ABKefir within 30 minutes after breakfast, and once a day.
High dose of ABKefir
High dose of probiotics, 1×10\^10 CFU/capsule
Probiotics (ABKefir)
Take a capsule of ABKefir within 30 minutes after breakfast, and once a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Take a capsule of placebo within 30 minutes after breakfast, and once a day.
Probiotics (ABKefir)
Take a capsule of ABKefir within 30 minutes after breakfast, and once a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-75 years old
* fulfill Rome IV criteria for functional constipation
* have not participated in similar research in the past three months
Exclusion Criteria
* Irritable bowel syndrome diagnosed during colonoscopy
* Those who are pregnant recently (including men and women), or are pregnant or breastfeeding women.
* Taking antidepressants, anti-anxiety drugs and other psychotropic drugs.
* Long-term medication is required to improve constipation
* Those diagnosed with myocardial infarction, cerebral infarction, malignant tumor and/or other serious diseases are not suitable for participating in the study.
* Allergic symptoms to probiotics or any ingredients
* Having a history of serious mental illness
* Drug-related crimes or alcohol problems
* Have recently traveled to areas where parasitic diseases are prevalent.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SYNBIO TECH INC. Kaohsiung Taiwan
UNKNOWN
Chung Shan Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hsin-Chi Pan, MS student
Role: PRINCIPAL_INVESTIGATOR
Chung Shan Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chung Shan Medical University
Taichung, South, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS2-24134
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.